These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 24430672)
1. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review). Wang SW; Sun YM Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672 [TBL] [Abstract][Full Text] [Related]
2. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC. Wang S; Zhang W Tumour Biol; 2016 May; 37(5):6561-9. PubMed ID: 26638167 [TBL] [Abstract][Full Text] [Related]
3. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236 [TBL] [Abstract][Full Text] [Related]
4. Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells. Wei X; Wang G; Li W; Hu X; Huang Q; Xu K; Lou W; Wu J; Liang C; Lou Q; Qian C; Liu L Oncol Rep; 2014 Jan; 31(1):335-41. PubMed ID: 24253664 [TBL] [Abstract][Full Text] [Related]
5. 17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells. Wang Y; Ma X; Yan S; Shen S; Zhu H; Gu Y; Wang H; Qin G; Yu Q Cancer Res; 2009 Sep; 69(18):7302-10. PubMed ID: 19706767 [TBL] [Abstract][Full Text] [Related]
6. Effect of Rhizoma paridis total saponins on apoptosis of colorectal cancer cells and imbalance of the JAK/STAT3 molecular pathway induced by IL-6 suppression. Teng WJ; Chen P; Zhu FY; Di K; Zhou C; Zhuang J; Cao XJ; Yang J; Deng LJ; Sun CG Genet Mol Res; 2015 May; 14(2):5793-803. PubMed ID: 26125778 [TBL] [Abstract][Full Text] [Related]
7. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway. Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185 [TBL] [Abstract][Full Text] [Related]
8. Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis. Jung IH; Choi JH; Chung YY; Lim GL; Park YN; Park SW Neoplasia; 2015 Jul; 17(7):586-97. PubMed ID: 26297436 [TBL] [Abstract][Full Text] [Related]
9. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels. Xu L; Chen X; Shen M; Yang DR; Fang L; Weng G; Tsai Y; Keng PC; Chen Y; Lee SO Mol Oncol; 2018 Mar; 12(3):269-286. PubMed ID: 28865178 [TBL] [Abstract][Full Text] [Related]
11. Curcuminoids Modulated the IL-6/JAK/STAT3 Signaling Pathway in LoVo and HT-29 Colorectal Cancer Cells. Li Q; Ding Y; Ou Y; Li M; Jithavech P; Buranasudja V; Sritularak B; Xu Y; Rojsitthisak P; Han J Curr Pharm Des; 2023; 29(36):2867-2876. PubMed ID: 37957863 [TBL] [Abstract][Full Text] [Related]
12. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173 [TBL] [Abstract][Full Text] [Related]
13. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Johnson DE; O'Keefe RA; Grandis JR Nat Rev Clin Oncol; 2018 Apr; 15(4):234-248. PubMed ID: 29405201 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells. Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell. Zhang J; Jia J; Zhao L; Li X; Xie Q; Chen X; Wang J; Lu F Mol Carcinog; 2016 May; 55(5):732-42. PubMed ID: 25809226 [TBL] [Abstract][Full Text] [Related]
16. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice. Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257 [TBL] [Abstract][Full Text] [Related]
17. Targeting JAK kinase in solid tumors: emerging opportunities and challenges. Buchert M; Burns CJ; Ernst M Oncogene; 2016 Feb; 35(8):939-51. PubMed ID: 25982279 [TBL] [Abstract][Full Text] [Related]
18. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling. Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465 [TBL] [Abstract][Full Text] [Related]
19. Activation of JAK-STAT3 signaling pathway in chronic subdural hematoma outer membranes. Osuka K; Watanabe Y; Usuda N; Atsuzawa K; Shima H; Takeuchi M; Yasuda M; Takayasu M Neurosci Lett; 2013 Feb; 534():166-70. PubMed ID: 23174178 [TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes. Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]